谁应在2009年获得转复除颤器心脏猝死的一级及二级预防(英文)课件.pptVIP

谁应在2009年获得转复除颤器心脏猝死的一级及二级预防(英文)课件.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
谁应在2009年获得转复除颤器心脏猝死的一级及二级预防(英文)课件

Who Should Receive a Defibrillator in 2009? Primary and Secondary Prevention of Sudden Cardiac Death ;CP1270808-8;Pathophysiology and Epidemiology of Sudden Death from Cardiac Causes;Secondary prevention trials all patients had aborted cardiac arrest or syncope ;AVID Antiarrhythmics Versus Implantable Defibrillators secondary sudden death prevention trial;Antiarrhythmic-drug group;ICD Primary Prevention;MADIT II Multicenter Automatic Defibrillator Implantation Trial;MADIT II: Survival with ICD vs Conventional Therapy;Inclusion: recent MI (6-40 days) LVEF ? 35 % depressed HRV (SDNN ? 70 msec or 24 h mean RR ? 750 msec) Exclusion: CABG/PCI expected within 4 weeks after randomization N: 674 Therapy: Conventional vs. ICD Primary outcome: mortality from all causes;CP1242180-13;SCD-HeFT Amiodarone or an ICD for Congestive Heart Failure ;No. at risk Placebo 847 797 724 505 304 89 Amiodarone 845 772 715 484 280 97 ICD therapy 829 778 733 501 304 103;Kaplan-Meier Estimates of Death from Any Cause; 10 ICD Primary Prevention Randomized Trials; total n mortality ------------------------------------------------------------------------ Non-ICD therapy 3,723 26.4% ICD therapy 3,530 18.5% Absolute mortality reduction 8% Relative mortality reduction 25% ;ICD efficacy in risk subgroups ;In ICD primary prevention of sudden death trials, patients with NYHA class IV were excluded.;Reprinted with permission from Elsevier Science (The Lancet, 1999;353:2001-2007). MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). LANCET. 1999;353:2005. ;ICD indication….Class I;ICD indication….Class III;Causes of Death in HCM 744 Patients – 125 Deaths;Hypertrophic Cardiomyopathy;A 30 yo male with a FH sudden death and LVH 27mm, received a ICD 4-month later…. ;Arrhythmogenic Right Ventricular Cardiomyopathy; ;Case #1;What would you do next?

文档评论(0)

2017meng + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档